Jazz Pharmaceuticals
JAZZ | NASDAQ
$215.98
+$8.15 (+3.92%)
At close: Oct 30, 2026, 4:00 PM ET
$215.98
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 8:26 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -29.11 | 13.59 | 18.78 | -44.50 | -23.12 | 38.56 |
PEG Ratio | 0.18 | 0.35 | -0.07 | 1.27 | 0.10 | -0.72 |
PS Ratio | 2.43 | 1.87 | 2.03 | 2.72 | 2.46 | 3.89 |
PB Ratio | 2.40 | 1.86 | 2.08 | 3.23 | 1.92 | 2.51 |
P/FCF Ratio | 9.05 | 5.65 | 7.29 | 12.88 | 10.38 | 17.67 |
P/OCF Ratio | 7.65 | 5.46 | 7.13 | 7.83 | 9.77 | 10.22 |
OCF/S Ratio | 31.77 | 34.31 | 28.48 | 34.76 | 25.16 | 38.06 |
Debt / Equity Ratio | 1.26 | 1.51 | 1.55 | 1.88 | 1.55 | 0.61 |
Quick Ratio | 1.67 | 3.99 | 1.85 | 2.03 | 1.90 | 4.20 |
Current Ratio | 1.86 | 4.46 | 2.24 | 2.79 | 3.23 | 4.34 |
Asset Turnover | 0.37 | 0.34 | 0.34 | 0.34 | 0.25 | 0.36 |
Interest Coverage | 1.15 | 3.01 | 2 | -0.23 | 0.61 | 3.79 |
Return on Equity | -8.25% | 13.68% | 11.10% | -7.26% | -8.30% | 6.52% |
Return on Assets | -3.05% | 4.66% | 3.64% | -2.07% | -2.67% | 3.65% |
Return on Invested Capital | 1.22% | 6.50% | 5.52% | -0.39% | 1.48% | 5.40% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 88.21% | 89.05% | 88.64% | 85.23% | 85.76% | 93.70% |
Net Profit Margin | -8.35% | 13.77% | 10.82% | -6.12% | -10.63% | 10.10% |
Pretax Profit Margin | -14.73% | 11.52% | 7.69% | -10.46% | -3.67% | 11.51% |
Operating Profit Margin | 5.26% | 17.61% | 15.09% | -1.79% | 5.50% | 16% |
FCF Margin | 26.85% | 33.13% | 27.86% | 21.15% | 23.69% | 22.02% |
EBITDA Margin | 2.54% | 37.40% | 37.80% | 40.13% | 33.21% | 44.16% |
Add to Watchlist
Select watchlists to add or remove JAZZ